Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Central African Republic
Central African Republic: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati was 45.0% in 2025. ◆ Volatile
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Central African Republic, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Central African Republic is 45.0%, measured in 2025.
The figure is up 7.1% on the previous year and up 2.3% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Central African Republic peaked at 47.0% in 2012 and was at its lowest, 0.0%, in 2008.
Central African Republic ranks 158th of 194 groups on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 32.7% | 0.0% | 47.0% | 10 |
| 2020s | 38.0% | 32.0% | 45.0% | 6 |
Countries ranked near Central African Republic
- 155 Azerbaijan 52.0% compare
- 156 Kazakhstan 49.0% compare
- 156 Chad 49.0% compare
- 159 Papua New Guinea 44.0% compare
- 160 Haiti 39.0% compare
- 160 Yemen 39.0% compare
More health data for Central African Republic
- Un projection of annual infant deaths 5,728 (2100)
- Heat deaths vs projected death rates 887.2 (2090)
- Deaths in armed conflicts by region 0 (2026)
- Deaths in armed conflicts by country 0 (2026)
- Population ages 15-64, female 51.1% (2025)
- Age population, age 17, male, interpolated 66,113 (2025)
- Age population, age 17, female, interpolated 66,112 (2025)
- Age population, age 16, male, interpolated 68,023 (2025)
- Age population, age 16, female, interpolated 67,969 (2025)
- Population ages 15-64, male 47.0% (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Central African Republic?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Central African Republic was 45.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Central African Republic?
- The highest recorded value was 47.0% in 2012.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Central African Republic?
- The lowest recorded value was 0.0% in 2008.
- How does Central African Republic rank for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Central African Republic ranks 158th out of 194 groups with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati rising or falling in Central African Republic?
- Over the last ten years it is up 2.3%. The long-run trend across the full record is volatile.
- Where does this Central African Republic data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).